Paper 19 - IS THERE A ROLE FOR MIFAMURTIDE IN NONMETASTATIC EXTREMITY HIGH-GRADE OSTEOSARCOMA PATIENTS? RESULTS OF PROSPECTIVE ITALIAN SARCOMA GROUP (ISG/OS-2) AND SPANISH SARCOMA GROUP (GEIS-33) TRIALS

Author(s)

• 

  Emanuela Palmerini, MD, PhD

  Consultant Medical oncologist
  IRCCS Istituto Ortopedico Rizzoli
  Bologna, Emilia-Romagna, Italy

Co-Author(s)

• CM

  Cristina Meazza, MD

  Pediatric Oncology Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori,
  Mlano, Lombardia, Italy
• AT

  Angela Tamburini, MD

  AOU Meyer IRCCS
  Firenze, Toscana, Italy
• CM

  Catalina Márquez-Vega, MD

  ediatric Oncology Unit, Hospital Infantil Universitario Virgen del Rocío
  Sevilla, Andalucia, Spain
• GB

  Gianni Bisogno, MD, Prof

  Univeristy of Padua
  Padua, Veneto, Italy
• FF

  Franca Fagioli, MD, Prof

  University of Turin
  Turin, Piemonte, Italy
• VF

  Virginia Ferraresi, MD

  IRCCS Istituto Nazionale Tumori Regina Elena
  Rome, Lazio, Italy
• GM

  Giuseppe Maria Milano, MD

  8. Division of Pediatric Hematology and Oncology, Gene and Cellular Therapy, IRCCS Ospedale Pediatrico Bambino Gesù
  Roma, Lazio, Italy
• LC

  Luca Coccoli, MD

  Stem Cell Transplantation, S. Chiara Hospital, AOUP, Pisa,
  Pisa, Toscana, Italy
• AR

  Alba Rubio Simon, MD

  Hospital Infantil Universitario Niño Jesús
  Madrid, Madrid, Spain
• OG

  Oscar Gallego, MD

  Hospital de la Santa Creu i Sant Pau
  Barcelona, Catalonia, Spain
• ML

  María Esther Llinares Riestra, MD

  Pediatric Oncology Unit, Hospital Infantil Universitario Clinico Virgen de la Arrixca
  Murcia, Murcia, Spain
• CM

  Carla Manzitti, MD

  IRCCS Istituto Giannina Gaslini
  Genova, Liguria, Italy
• JM

  Jaume Mora, MD, PhD

  Hospital Sant Joan de Déu
  Barcelona, Catalonia, Spain
• MV

  Mª Ángeles Vaz-Salgado, MD, Prof

  Hospital Universitario Ramón y Cajal, Irycis
  Madrid, Madrid, Spain
• RL

  Roberto Luksch, MD

  2. S.C. Oncologia Pediatrica, Fondazione IRCCS Istituto Nazionale dei Tumori
  Milan, Lombardia, Italy
• CM

  Cristina Mata, MD

  Hospital General Universitario Gregorio Marañón
  Madrid, Madrid, Spain
• MP

  Michela Pierini, PhD

  Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy
  Bologna, Emilia-Romagna, Italy
• EC

  Eisa Carretta, Bsc

  Department of Programming and Monitoring, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy
  Bologna, Emilia-Romagna, Italy
• MC

  Marilena Cesari, MD

  IRCCS Istituto Ortopedico Rizzoli
  Bologna, Emilia-Romagna, Italy
• AP

  Anna Paioli, MD

  IRCCS Istituto Ortopedico Rizzoli
  Bologna, Emilia-Romagna, Italy
• AM

  Andrea Marrari, MD

  IRCCS Istituto Ortopedico Rizzoli
  Bologna, Emilia-Romagna, Italy
• 

  Massimo Serra (he/him/his)

  Staff Researcher
  IRCCS Istituto Ortopedico Rizzoli
  Bologna, Emilia-Romagna, Italy
• KS

  Katia Scotlandi, PhD

  IRCCS Istituto Orthopedico Rizzoli
  Bologna, Emilia-Romagna, Italy
• SA

  Sebastian Dorin Asaftei, MD

  Regina Margherita Children Hospital
  Turin, Piemonte, Italy
• 

  Marco Gambarotti, MD

  Medical Doctor
  Department of Pathology, IRCCS, Istituto Ortopedico Rizzoli
  Bologna, Emilia-Romagna, Italy
• 

  Claudia Valverde, MD, PhD (she/her/hers)

  Senior consultant in Oncology
  Hospital Universitari Vall d’Hebron
  Barcelona, Catalonia, Spain
• TI

  Toni Ibrahim, MD, PhD, MSc

  Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS, Istituto Ortopedico Rizzoli, Bologna, Italy
  Bologna, Emilia-Romagna, Italy
• JM

  Javier Martín Broto, MD

  Hospital Universitario Fundación Jiménez Díaz
  Madrid, Madrid, Spain